{
  "resourceType" : "Bundle",
  "id" : "bundlejpicarbamazepine200",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"]
  },
  "language" : "ja",
  "identifier" : {
    "system" : "https://www.pmda.jp/",
    "value" : "jpiplaceholder"
  },
  "type" : "document",
  "timestamp" : "2002-08-01T13:28:17Z",
  "entry" : [{
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Composition/carbamazepine200jpi",
    "resource" : {
      "resourceType" : "Composition",
      "id" : "carbamazepine200jpi",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"]
      },
      "language" : "ja",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"ja\" lang=\"ja\"><p><b>Generated Narrative: Composition</b><a name=\"carbamazepine200jpi\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;carbamazepine200jpi&quot;  (Language &quot;ja&quot;) </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0fcats34placeholder</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>date</b>: 2002-08-01 13:28:17+0000</p><p><b>author</b>: <a href=\"#Organization_orgfujinaga\">See above (Organization/orgfujinaga)</a></p><p><b>title</b>: Tegretol (carbamazepine) 200 mg for tablet</p><h3>Attesters</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style=\"display: none\">*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-composition-attestation-mode.html\">Composition Attestation Mode</a>#official)</span></td><td>2002-08-01 13:28:17+0000</td></tr></table></div>"
      },
      "identifier" : [{
        "system" : "https://spor.ema.europa.eu/rmswi/",
        "value" : "fcats34placeholder"
      }],
      "status" : "final",
      "type" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/",
          "code" : "100000155538"
        }],
        "text" : "Package Leaflet"
      },
      "subject" : [{
        "reference" : "MedicinalProductDefinition/medprodcarbamazepine200"
      }],
      "date" : "2002-08-01T13:28:17Z",
      "author" : [{
        "reference" : "Organization/orgfujinaga"
      }],
      "title" : "Tegretol (carbamazepine) 200 mg for tablet",
      "attester" : [{
        "mode" : {
          "coding" : [{
            "system" : "http://hl7.org/fhir/composition-attestation-mode",
            "code" : "official"
          }]
        },
        "time" : "2002-08-01T13:28:17Z"
      }],
      "section" : [{
        "title" : "アロマターゼ阻害剤/閉経後乳癌治療剤",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "0"
          }],
          "text" : "アロマターゼ阻害剤/閉経後乳癌治療剤"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "1. 警告",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "1"
          }],
          "text" : "1. 警告"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "1.1",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "2.1"
            }],
            "text" : "1.1"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "1.2",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "2.1"
            }],
            "text" : "1.2"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "1.3",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "2.1"
            }],
            "text" : "1.3"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "2. 禁忌(次の患者には投与しないこと)",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "2"
          }],
          "text" : "禁忌(次の患者には投与しないこと)"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "2.1",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "2.1"
            }],
            "text" : "2.1"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "2.2",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "2.2"
            }],
            "text" : "2.2"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "2.3",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "2.3"
            }],
            "text" : "2.3"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "3. 組成・性状",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "3"
          }],
          "text" : "3. 組成・性状"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "3.1 組成",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "3.1"
            }],
            "text" : "3.1 組成"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "3.2 製剤の性状",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "3.2"
            }],
            "text" : "3.2 製剤の性状"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "4. 効能又は効果",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "4"
          }],
          "text" : "効能又は効果"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "5. 効能又は効果に関連する注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "5"
          }],
          "text" : "効能又は効果に関連する注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "6. 用法及び用量",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "6"
          }],
          "text" : "用法及び用量"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "7. 用法及び用量に関連する注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "7"
          }],
          "text" : "7. 用法及び用量に関連する注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "8. 重要な基本的注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "8"
          }],
          "text" : "重要な基本的注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "8.1",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "8.1"
            }],
            "text" : "8.1"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "8.2",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "8.2"
            }],
            "text" : "8.2"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "8.3",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "8.3"
            }],
            "text" : "8.3"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "8.4",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "8.4"
            }],
            "text" : "8.4"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "9. 特定の背景を有する患者に関する注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "9"
          }],
          "text" : "特定の背景を有する患者に関する注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "9.1",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9.2"
            }],
            "text" : "9.1"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "9.2 腎機能障害患者",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9.2"
            }],
            "text" : "9.2 腎機能障害患者"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "9.2.1 重度の腎障害のある患者",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "9"
              }],
              "text" : "9.2.1 重度の腎障害のある患者"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "9.3 肝機能障害患者",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9.3"
            }],
            "text" : "9.3 肝機能障害患者"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "9.3.1 重度の肝障害のある患者",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "9.3.1"
              }],
              "text" : "9.3.1 重度の肝障害のある患者"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "9.4",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9.4"
            }],
            "text" : "9.4"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "9.5 妊婦",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9"
            }],
            "text" : "9.5 妊婦"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "9.6 授乳婦",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9.6"
            }],
            "text" : "9.6 授乳婦"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "10. 相互作用",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "10"
          }],
          "text" : "10. 相互作用"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "10.1",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "9"
            }],
            "text" : "10.1"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "10.2 併用注意(併用に注意すること)",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "10"
            }],
            "text" : "10.2 併用注意(併用に注意すること)"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "11. 副作用",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "11"
          }],
          "text" : "11. 副作用"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "11.1 重大な副作用",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "11.1"
            }],
            "text" : "11.1 重大な副作用"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "11.1.1",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "11.1.1"
              }],
              "text" : "11.1.1"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "11.2 その他の副作用",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "11.2"
            }],
            "text" : "11.2 その他の副作用"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "12. 臨床検査結果に及ぼす影響",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "12"
          }],
          "text" : "12. 臨床検査結果に及ぼす影響"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "13. 過量投与",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "13"
          }],
          "text" : "13. 過量投与"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "14. 適用上の注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "14"
          }],
          "text" : "14. 適用上の注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "14.1 薬剤交付時の注意",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "14.1"
            }],
            "text" : "14.1 薬剤交付時の注意"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "15. その他の注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "13"
          }],
          "text" : "15. その他の注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "15.1",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "15.1"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "15.2 非臨床試験に基づく情報",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "15.2 非臨床試験に基づく情報"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        }]
      },
      {
        "title" : "16. 薬物動態",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "13"
          }],
          "text" : "16. 薬物動態"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "16.1 血中濃度",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "16.1 血中濃度"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "16.2 吸収",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "16.2 吸収"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "16.2.1 食事の影響",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.2.1 食事の影響"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "16.3 分布",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "16.3 分布"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "16.3.1 組織内濃度",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.3.1 組織内濃度"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "16.3.2 胎児・胎盤移行性",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.3.2 胎児・胎盤移行性"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "16.3.3 蛋白結合率",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.3.3 蛋白結合率"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "16.5 排泄",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "16.5 排泄"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "16.5.1",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.5.1"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "16.5.2",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.5.2"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "16.6 特定の背景を有する患者",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "16.6 特定の背景を有する患者"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "16.6.1 腎機能障害患者における体内動態",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.6.1 腎機能障害患者における体内動態"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "16.6.2 肝機能障害患者における体内動態",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "16.6.2 肝機能障害患者における体内動態"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        }]
      },
      {
        "title" : "17. 臨床成績",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "17"
          }],
          "text" : "17. 臨床成績"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "17.1 有効性及び安全性に関する試験",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "13"
            }],
            "text" : "17.1 有効性及び安全性に関する試験"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "17.1.1 国内臨床試験",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "17.1.1 国内臨床試験"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "17.1.2 ブリッジング試験",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "17.1.2 ブリッジング試験"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "17.1.3 海外臨床試験(第III相試験)",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "17.1.3 海外臨床試験(第III相試験)"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "17.1.4 海外大規模比較試験(第III相試験 術後補助療法)",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "17.1.4 海外大規模比較試験(第III相試験 術後補助療法)"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "17.1.5 海外比較試験(術後補助療法)",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "13"
              }],
              "text" : "17.1.5 海外比較試験(術後補助療法)"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "17.1.6 非盲検無作為化比較試験(第II/III相試験 転移性乳癌に対する第一次 ホルモン療法)",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "16"
              }],
              "text" : "17.1.6 非盲検無作為化比較試験(第II/III相試験 転移性乳癌に対する第一次 ホルモン療法)"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        }]
      },
      {
        "title" : "18. 薬効薬理",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "18"
          }],
          "text" : "18. 薬効薬理"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        },
        "section" : [{
          "title" : "18.1 作用機序",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "17"
            }],
            "text" : "18.1 作用機序"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "18.1.1 アロマターゼ阻害作用",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "17"
              }],
              "text" : "18.1.1 アロマターゼ阻害作用"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        },
        {
          "title" : "18.2 抗腫瘍効果",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "17"
            }],
            "text" : "18.2 抗腫瘍効果"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          }
        },
        {
          "title" : "18.3 エストロゲン抑制作用",
          "code" : {
            "coding" : [{
              "system" : "https://pmda.jp/",
              "code" : "17"
            }],
            "text" : "18.3 エストロゲン抑制作用"
          },
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
          },
          "section" : [{
            "title" : "18.3.1",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "17"
              }],
              "text" : "18.3.1"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          },
          {
            "title" : "18.3.2",
            "code" : {
              "coding" : [{
                "system" : "https://pmda.jp/",
                "code" : "17"
              }],
              "text" : "18.3.2"
            },
            "text" : {
              "status" : "additional",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            }
          }]
        }]
      },
      {
        "title" : "19. 有効成分に関する理化学的知見",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "19"
          }],
          "text" : "19. 有効成分に関する理化学的知見"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "20. 取扱い上の注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "9"
          }],
          "text" : "20. 取扱い上の注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "21. 承認条件",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "9"
          }],
          "text" : "21. 承認条件"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "22. 包装",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "22"
          }],
          "text" : "22. 包装"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "23. 主要文献",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "23"
          }],
          "text" : "23. 主要文献"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "24. 文献請求先及び問い合わせ先",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "24"
          }],
          "text" : "24. 文献請求先及び問い合わせ先"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "25. 保険給付上の注意",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "9"
          }],
          "text" : "25. 保険給付上の注意"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "26. 製造販売業者等",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "26"
          }],
          "text" : "26. 製造販売業者等"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      },
      {
        "title" : "26.1 製造販売元",
        "code" : {
          "coding" : [{
            "system" : "https://pmda.jp/",
            "code" : "26"
          }],
          "text" : "26.1 製造販売元"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
        }
      }]
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Organization/orgfujinaga",
    "resource" : {
      "resourceType" : "Organization",
      "id" : "orgfujinaga",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Organization</b><a name=\"orgfujinaga\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization &quot;orgfujinaga&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0fujinaga\u00a0(use:\u00a0OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#tbd)</span></p><p><b>name</b>: Fujinaga Pharmaceutical Co., Ltd.</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td>Medicine Consultation Office Front Place Nihonbashi 2-14-1 Nihonbashi, Chuo-ku,(WORK)</td></tr></table></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://pmda-org-id",
        "value" : "fujinaga"
      }],
      "active" : true,
      "type" : [{
        "coding" : [{
          "system" : "https://PMDA-org-type.jp/",
          "code" : "tbd",
          "display" : "Marketing authorisation holder"
        }],
        "text" : "Marketing authorisation holder"
      }],
      "name" : "Fujinaga Pharmaceutical Co., Ltd.",
      "contact" : [{
        "address" : {
          "use" : "work",
          "type" : "physical",
          "text" : "Medicine Consultation Office Front Place Nihonbashi 2-14-1 Nihonbashi, Chuo-ku,",
          "line" : ["2-14-1 Nihonbashi"],
          "city" : "Chuo-ku",
          "postalCode" : "103-8324",
          "country" : "Tokyo"
        }
      }]
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Authorizations/authcarbamazepine200",
    "resource" : {
      "resourceType" : "RegulatedAuthorization",
      "id" : "authcarbamazepine200",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authcarbamazepine200\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization &quot;authcarbamazepine200&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id:\u00a022700AMX00173\u00a0(use:\u00a0OFFICIAL)</p><p><b>subject</b>: <a href=\"#MedicinalProductDefinition_medprodcarbamazepine200\">See above (MedicinalProductDefinition/medprodcarbamazepine200)</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072062)</span></p><p><b>region</b>: Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 13:28:17+0000</p><p><b>holder</b>: <a href=\"#Organization_orgfujinaga\">See above (Organization/orgfujinaga)</a></p></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://pmda-approvalandlicenseno/",
        "value" : "22700AMX00173"
      }],
      "subject" : [{
        "reference" : "MedicinalProductDefinition/medprodcarbamazepine200"
      }],
      "type" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "/#100000072062"
        }],
        "text" : "Marketing Authorisation"
      },
      "region" : [{
        "coding" : [{
          "system" : "urn:iso:std:iso:3166",
          "code" : "JP"
        }],
        "text" : "Japan"
      }],
      "status" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/publication-status",
          "code" : "active"
        }],
        "text" : "Active"
      },
      "statusDate" : "2002-08-01T13:28:17Z",
      "holder" : {
        "reference" : "Organization/orgfujinaga"
      }
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/medprodcarbamazepine200",
    "resource" : {
      "resourceType" : "MedicinalProductDefinition",
      "id" : "medprodcarbamazepine200",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name=\"medprodcarbamazepine200\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicinalProductDefinition &quot;medprodcarbamazepine200&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a01139002F1070</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html\">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html\">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Tegretol (carbamazepine) 200 mg for tablet</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Tegretol</p><p><b>type</b>: Invented name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: carbamazepine</p><p><b>type</b>: Scientific name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 200 mg</p><p><b>type</b>: Strength part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: tablet</p><p><b>type</b>: Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td>Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></td><td>Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></td><td>Japanese (Region=Japan) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#ja-JP)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : [{
        "system" : "http://iyaku.info/medicine",
        "value" : "1139002F1070"
      }],
      "type" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/medicinal-product-type",
          "code" : "MedicinalProduct",
          "display" : "Medicinal Product"
        }]
      },
      "domain" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/medicinal-product-domain",
          "code" : "Human",
          "display" : "Human use"
        }]
      },
      "status" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/publication-status",
          "code" : "active",
          "display" : "active"
        }]
      },
      "legalStatusOfSupply" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "100000072084",
          "display" : "Medicinal product subject to medical prescription"
        }]
      },
      "name" : [{
        "productName" : "Tegretol (carbamazepine) 200 mg for tablet",
        "type" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/lists/220000000000",
            "code" : "220000000001"
          }],
          "text" : "Full name"
        },
        "part" : [{
          "part" : "Tegretol",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/lists/220000000000",
              "code" : "220000000002"
            }],
            "text" : "Invented name part"
          }
        },
        {
          "part" : "carbamazepine",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/lists/220000000000",
              "code" : "220000000003"
            }],
            "text" : "Scientific name part"
          }
        },
        {
          "part" : "200 mg",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/lists/220000000000",
              "code" : "220000000004"
            }],
            "text" : "Strength part"
          }
        },
        {
          "part" : "tablet",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/lists/220000000000",
              "code" : "220000000005"
            }],
            "text" : "Pharmaceutical dose form part"
          }
        }],
        "usage" : [{
          "country" : {
            "coding" : [{
              "system" : "urn:iso:std:iso:3166",
              "code" : "JP"
            }]
          },
          "jurisdiction" : {
            "coding" : [{
              "system" : "urn:iso:std:iso:3166",
              "code" : "JP"
            }]
          },
          "language" : {
            "coding" : [{
              "system" : "urn:ietf:bcp:47",
              "code" : "ja-JP"
            }]
          }
        }]
      }]
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/packcarbamazepine200",
    "resource" : {
      "resourceType" : "PackagedProductDefinition",
      "id" : "packcarbamazepine200",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"packcarbamazepine200\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource PackagedProductDefinition &quot;packcarbamazepine200&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0placeholder2\u00a0(use:\u00a0OFFICIAL)</p><p><b>name</b>: Tegretol (carbamazepine) 200 mg for tablet in bottles</p><p><b>type</b>: Chemical Medininal Prodcut <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: <a href=\"#MedicinalProductDefinition_medprodcarbamazepine200\">See above (MedicinalProductDefinition/medprodcarbamazepine200)</a></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 13:28:17+0000</p><p><b>containedItemQuantity</b>: 200 mg</p><p><b>manufacturer</b>: <a href=\"#Organization_orgfujinaga\">See above (Organization/orgfujinaga)</a></p><h3>Packagings</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style=\"display: none\">*</td><td>id:\u00a0123456</td><td>Bottle <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073497)</span></td><td>28</td><td>PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003222)</span></td></tr></table></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://pmda-packinsertno/",
        "value" : "placeholder2"
      }],
      "name" : "Tegretol (carbamazepine) 200 mg for tablet in bottles",
      "type" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "100000155527",
          "display" : "Chemical Medininal Prodcut"
        }]
      },
      "packageFor" : [{
        "reference" : "MedicinalProductDefinition/medprodcarbamazepine200"
      }],
      "status" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/publication-status",
          "code" : "active",
          "display" : "Active"
        }]
      },
      "statusDate" : "2002-08-01T13:28:17Z",
      "containedItemQuantity" : [{
        "value" : 200,
        "unit" : "mg"
      }],
      "manufacturer" : [{
        "reference" : "Organization/orgfujinaga"
      }],
      "packaging" : {
        "identifier" : [{
          "system" : "https://spor.ema.europa.eu/pmswi",
          "value" : "123456"
        }],
        "type" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "100000073497",
            "display" : "Bottle"
          }]
        },
        "quantity" : 28,
        "material" : [{
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "200000003222",
            "display" : "PolyVinyl Chloride"
          }]
        }]
      }
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/adminprodcarbamazepine200",
    "resource" : {
      "resourceType" : "AdministrableProductDefinition",
      "id" : "adminprodcarbamazepine200",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: AdministrableProductDefinition</b><a name=\"adminprodcarbamazepine200\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource AdministrableProductDefinition &quot;adminprodcarbamazepine200&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-AdministrableProductDefinition-uv-epi.html\">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0FB9808F4FED210183F412F9998622287</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href=\"#MedicinalProductDefinition_medprodcarbamazepine200\">See above (MedicinalProductDefinition/medprodcarbamazepine200)</a></p><p><b>administrableDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#10219000)</span></p><p><b>unitOfPresentation</b>: 15054000 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#15054000)</span></p><p><b>producedFrom</b>: <a href=\"#ManufacturedItemDefinition_manitemcarbamazepine200\">See above (ManufacturedItemDefinition/manitemcarbamazepine200)</a></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td>20053000 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#20053000)</span></td></tr></table></div>"
      },
      "identifier" : [{
        "system" : "https://www.who-umc.org/phpid",
        "value" : "FB9808F4FED210183F412F9998622287"
      }],
      "status" : "active",
      "formOf" : [{
        "reference" : "MedicinalProductDefinition/medprodcarbamazepine200"
      }],
      "administrableDoseForm" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "10219000"
        }],
        "text" : "Tablet"
      },
      "unitOfPresentation" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "15054000"
        }]
      },
      "producedFrom" : [{
        "reference" : "ManufacturedItemDefinition/manitemcarbamazepine200"
      }],
      "routeOfAdministration" : [{
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "20053000"
          }]
        }
      }]
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/manitemcarbamazepine200",
    "resource" : {
      "resourceType" : "ManufacturedItemDefinition",
      "id" : "manitemcarbamazepine200",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name=\"manitemcarbamazepine200\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ManufacturedItemDefinition &quot;manitemcarbamazepine200&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-ManufacturedItemDefinition-uv-epi.html\">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0placeholder\u00a0(use:\u00a0OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#10219000)</span></p><p><b>unitOfPresentation</b>: 15054000 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#15054000)</span></p><p><b>manufacturer</b>: <a href=\"#Organization_orgfujinaga\">See above (Organization/orgfujinaga)</a></p></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://pmda-sccj",
        "value" : "placeholder"
      }],
      "status" : "active",
      "manufacturedDoseForm" : {
        "coding" : [{
          "system" : "https://standardterms.edqm.eu/browse/get_concepts_by/SOM/SOM/",
          "code" : "10219000"
        }],
        "text" : "Tablet"
      },
      "unitOfPresentation" : {
        "coding" : [{
          "system" : "https://standardterms.edqm.eu/browse/get_concepts/UOP/",
          "code" : "15054000"
        }]
      },
      "manufacturer" : [{
        "reference" : "Organization/orgfujinaga"
      }]
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/carbamazepine",
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "carbamazepine",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b><a name=\"carbamazepine\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;carbamazepine&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id:\u00a033CM23913M\u00a0(use:\u00a0OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_manitemcarbamazepine200\">See above (ManufacturedItemDefinition/manitemcarbamazepine200)</a></p><p><b>role</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072072)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"#Organization_orgfujinaga\">See above (Organization/orgfujinaga)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>carbamazepine <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#33CM23913M)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style=\"display: none\">*</td><td>200 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : {
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "33CM23913M"
      },
      "status" : "active",
      "for" : [{
        "reference" : "ManufacturedItemDefinition/manitemcarbamazepine200"
      }],
      "role" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "100000072072",
          "display" : "Active"
        }]
      },
      "manufacturer" : [{
        "manufacturer" : {
          "reference" : "Organization/orgfujinaga"
        }
      }],
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
              "code" : "33CM23913M",
              "display" : "carbamazepine"
            }]
          }
        },
        "strength" : [{
          "presentationQuantity" : {
            "value" : 200,
            "unit" : "mg"
          },
          "basis" : {
            "coding" : [{
              "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
              "code" : "ACTIB"
            }],
            "text" : "active ingredient - basis of strength"
          }
        }]
      }
    }
  },
  {
    "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/subcarbamazepine200",
    "resource" : {
      "resourceType" : "SubstanceDefinition",
      "id" : "subcarbamazepine200",
      "meta" : {
        "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: SubstanceDefinition</b><a name=\"subcarbamazepine200\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource SubstanceDefinition &quot;subcarbamazepine200&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-SubstanceDefinition-uv-epi.html\">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a033CM23913M\u00a0(use:\u00a0OFFICIAL)</p><p><b>version</b>: 39</p><p><b>status</b>: Validated (UNII) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#1)</span></p><p><b>description</b>: White to pale yellow</p><p><b>manufacturer</b>: <a href=\"#Organization_orgfujinaga\">See above (Organization/orgfujinaga)</a></p><h3>Structures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>MolecularFormula</b></td></tr><tr><td style=\"display: none\">*</td><td>C15H12N2O</td></tr></table><h3>Names</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style=\"display: none\">*</td><td>carbamazepine</td><td>Chemical Name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#1)</span></td></tr></table></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "33CM23913M"
      }],
      "version" : "39",
      "status" : {
        "coding" : [{
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "code" : "1"
        }],
        "text" : "Validated (UNII)"
      },
      "description" : "White to pale yellow",
      "manufacturer" : [{
        "reference" : "Organization/orgfujinaga"
      }],
      "structure" : {
        "molecularFormula" : "C15H12N2O"
      },
      "name" : [{
        "name" : "carbamazepine",
        "type" : {
          "coding" : [{
            "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
            "code" : "1"
          }],
          "text" : "Chemical Name"
        }
      }]
    }
  }]
}